Comments
Loading...

Viavi Solutions Analyst Ratings

VIAVNASDAQ
Logo brought to you by Benzinga Data
$10.27
-0.12-1.15%
At close: -
$9.90
-0.37-3.59%
After Hours: Jul 11, 5:49 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$16.00
Lowest Price Target1
$8.00
Consensus Price Target1
$12.32

Viavi Solutions Analyst Ratings and Price Targets | NASDAQ:VIAV | Benzinga

Viavi Solutions Inc has a consensus price target of $12.32 based on the ratings of 12 analysts. The high is $16 issued by Argus Research on February 5, 2025. The low is $8 issued by Morgan Stanley on April 8, 2025. The 3 most-recent analyst ratings were released by Rosenblatt, UBS, and B. Riley Securities on June 20, 2025, May 2, 2025, and May 2, 2025, respectively. With an average price target of $11.83 between Rosenblatt, UBS, and B. Riley Securities, there's an implied 19.52% upside for Viavi Solutions Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Mar
1
1
Apr
2
2
May
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.9
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Rosenblatt
UBS
B. Riley Securities
Needham
Morgan Stanley

1calculated from analyst ratings

Analyst Ratings for Viavi Solutions

Buy NowGet Alert
06/20/2025Buy Now36.35%Rosenblatt
Mike Genovese
$13.5 → $13.5MaintainsBuyGet Alert
05/02/2025Buy Now11.1%UBS
Andrew Spinola
$11.5 → $11MaintainsNeutralGet Alert
05/02/2025Buy Now11.1%B. Riley Securities
Dave Kang
$12 → $11MaintainsNeutralGet Alert
05/02/2025Buy Now36.35%Rosenblatt
Mike Genovese
$12 → $13.5MaintainsBuyGet Alert
05/02/2025Buy Now51.5%Needham
Ryan Koontz
$15 → $15ReiteratesBuy → BuyGet Alert
04/22/2025Buy Now21.2%Rosenblatt
Mike Genovese
$14 → $12MaintainsBuyGet Alert
04/08/2025Buy Now-19.2%Morgan Stanley
Meta Marshall
$10 → $8MaintainsUnderweightGet Alert
03/07/2025Buy Now41.4%Rosenblatt
Mike Genovese
→ $14UpgradeNeutral → BuyGet Alert
02/05/2025Buy Now61.6%Argus Research
Jim Kelleher
$13 → $16MaintainsBuyGet Alert
01/31/2025Buy Now16.15%UBS
Andrew Spinola
$10.6 → $11.5MaintainsNeutralGet Alert
01/31/2025Buy Now21.2%B. Riley Securities
Dave Kang
$10 → $12MaintainsNeutralGet Alert
01/31/2025Buy Now31.3%Stifel
Ruben Roy
$12 → $13ReiteratesBuy → BuyGet Alert
01/31/2025Buy Now1%Morgan Stanley
Meta Marshall
$9.5 → $10MaintainsUnderweightGet Alert
01/31/2025Buy Now51.5%Needham
Ryan Koontz
→ $15UpgradeHold → BuyGet Alert
01/31/2025Buy Now41.4%Northland Capital Markets
Tim Savageaux
$13 → $14ReiteratesOutperform → OutperformGet Alert
12/17/2024Buy Now-4.05%Morgan Stanley
Meta Marshall
$8 → $9.5DowngradeEqual-Weight → UnderweightGet Alert
12/16/2024Buy Now21.2%Stifel
Ruben Roy
$10.5 → $12MaintainsBuyGet Alert
12/16/2024Buy Now—Needham
Ryan Koontz
—ReiteratesHold → HoldGet Alert
11/19/2024Buy Now7.06%UBS
Andrew Spinola
→ $10.6Initiates → NeutralGet Alert
11/01/2024Buy Now31.3%Northland Capital Markets
Tim Savageaux
$11 → $13MaintainsOutperformGet Alert
11/01/2024Buy Now6.05%Rosenblatt
Mike Genovese
$8.25 → $10.5MaintainsNeutralGet Alert
11/01/2024Buy Now—Needham
Ryan Koontz
—Reiterates → HoldGet Alert
08/09/2024Buy Now-14.15%B. Riley Securities
Dave Kang
$9 → $8.5MaintainsNeutralGet Alert
08/09/2024Buy Now—Needham
Ryan Koontz
—Reiterates → HoldGet Alert
08/06/2024Buy Now6.05%Stifel
Ruben Roy
$13 → $10.5MaintainsBuyGet Alert
06/26/2024Buy Now-16.67%Rosenblatt
Mike Genovese
$10 → $8.25DowngradeBuy → NeutralGet Alert
05/03/2024Buy Now1%Rosenblatt
Mike Genovese
$13 → $10MaintainsBuyGet Alert
05/03/2024Buy Now—Needham
Ryan Koontz
—Reiterates → HoldGet Alert
04/03/2024Buy Now31.3%Rosenblatt
Mike Genovese
$15 → $13MaintainsBuyGet Alert
04/01/2024Buy Now31.3%Stifel
Ruben Roy
$13 → $13MaintainsBuyGet Alert
04/01/2024Buy Now—Needham
Alex Henderson
—Reiterates → HoldGet Alert
03/07/2024Buy Now41.4%Susquehanna
Mehdi Hosseini
$12 → $14MaintainsPositiveGet Alert
03/06/2024Buy Now71.7%Northland Capital Markets
Tim Savageaux
$12 → $17MaintainsOutperformGet Alert
03/06/2024Buy Now11.1%Morgan Stanley
Meta Marshall
$9 → $11MaintainsEqual-WeightGet Alert
03/06/2024Buy Now51.5%Rosenblatt
Mike Genovese
$13 → $15MaintainsBuyGet Alert
02/12/2024Buy Now31.3%Stifel
Ruben Roy
$10 → $13UpgradeHold → BuyGet Alert
12/13/2023Buy Now21.2%Rosenblatt
Mike Genovese
$10 → $12MaintainsBuyGet Alert
11/03/2023Buy Now1%Rosenblatt
Mike Genovese
$14 → $10MaintainsBuyGet Alert
11/03/2023Buy Now-9.1%Morgan Stanley
Connor Lynagh
$10 → $9MaintainsEqual-WeightGet Alert
08/31/2023Buy Now41.4%Rosenblatt
Mike Genovese
→ $14ReiteratesBuy → BuyGet Alert
08/11/2023Buy Now41.4%Rosenblatt
Mike Genovese
$13 → $14MaintainsBuyGet Alert
06/09/2023Buy Now31.3%Rosenblatt
Mike Genovese
→ $13ReiteratesBuy → BuyGet Alert
05/03/2023Buy Now1%Morgan Stanley
Connor Lynagh
$10.5 → $10MaintainsEqual-WeightGet Alert
05/03/2023Buy Now21.2%Susquehanna
Mehdi Hosseini
$14 → $12MaintainsPositiveGet Alert
05/03/2023Buy Now31.3%Rosenblatt
Mike Genovese
→ $13Reiterates → BuyGet Alert
04/18/2023Buy Now11.1%B. Riley Securities
Dave Kang
$13.5 → $11MaintainsNeutralGet Alert
04/18/2023Buy Now41.4%Susquehanna
Mehdi Hosseini
$16 → $14MaintainsPositiveGet Alert
04/18/2023Buy Now6.05%Morgan Stanley
Connor Lynagh
$13 → $10.5MaintainsEqual-WeightGet Alert
04/18/2023Buy Now31.3%Rosenblatt
Mike Genovese
$16 → $13MaintainsBuyGet Alert
02/03/2023Buy Now36.35%B. Riley Securities
Dave Kang
$14.5 → $13.5MaintainsNeutralGet Alert
12/20/2022Buy Now11.1%JP Morgan
Samik Chatterjee
$13 → $11MaintainsNeutralGet Alert
12/02/2022Buy Now21.2%Stifel
Ruben Roy
→ $12Initiates → HoldGet Alert
11/07/2022Buy Now31.3%Morgan Stanley
Meta Marshall
$16 → $13MaintainsEqual-WeightGet Alert
11/04/2022Buy Now46.45%B. Riley Securities
Dave Kang
$21 → $14.5DowngradeBuy → NeutralGet Alert
10/11/2022Buy Now61.6%Morgan Stanley
Meta Marshall
$17 → $16MaintainsEqual-WeightGet Alert
10/06/2022Buy Now81.8%Rosenblatt
Mike Genovese
→ $18Initiates → BuyGet Alert
09/14/2022Buy Now71.7%Morgan Stanley
Meta Marshall
$16 → $17MaintainsEqual-WeightGet Alert
08/12/2022Buy Now81.8%Susquehanna
Mehdi Hosseini
$20 → $18MaintainsPositiveGet Alert
07/19/2022Buy Now—Needham
Alex Henderson
—DowngradeBuy → HoldGet Alert
07/14/2022Buy Now51.5%JP Morgan
Samik Chatterjee
$18 → $15MaintainsNeutralGet Alert

FAQ

Q

What is the target price for Viavi Solutions (VIAV) stock?

A

The latest price target for Viavi Solutions (NASDAQ:VIAV) was reported by Rosenblatt on June 20, 2025. The analyst firm set a price target for $13.50 expecting VIAV to rise to within 12 months (a possible 36.35% upside). 25 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Viavi Solutions (VIAV)?

A

The latest analyst rating for Viavi Solutions (NASDAQ:VIAV) was provided by Rosenblatt, and Viavi Solutions maintained their buy rating.

Q

When was the last upgrade for Viavi Solutions (VIAV)?

A

The last upgrade for Viavi Solutions Inc happened on March 7, 2025 when Rosenblatt raised their price target to $14. Rosenblatt previously had a neutral for Viavi Solutions Inc.

Q

When was the last downgrade for Viavi Solutions (VIAV)?

A

The last downgrade for Viavi Solutions Inc happened on December 17, 2024 when Morgan Stanley changed their price target from $8 to $9.5 for Viavi Solutions Inc.

Q

When is the next analyst rating going to be posted or updated for Viavi Solutions (VIAV)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Viavi Solutions, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Viavi Solutions was filed on June 20, 2025 so you should expect the next rating to be made available sometime around June 20, 2026.

Q

Is the Analyst Rating Viavi Solutions (VIAV) correct?

A

While ratings are subjective and will change, the latest Viavi Solutions (VIAV) rating was a maintained with a price target of $13.50 to $13.50. The current price Viavi Solutions (VIAV) is trading at is $9.90, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch